13F

JAZZ Jazz Pharmaceuticals plc

2026Q1 · CUSIP G50871105 · Sector: Healthcare & Biotech

Cooling · Breadth rolling over
Holders
568
Δ holders QoQ
0
Breadth percentile
Top 62%
Whale holders
222
Δ whales
-7
Inst. holding value
$12.1B
New positions
92
Closed positions
92
Price momentum (1Q)
Put / Call
9/8

Breadth history (34 quarters)

2018Q1: Δ+2 · h=320 2018Q2: Δ+49 · h=369 2018Q3: Δ+25 · h=394 2018Q4: Δ+12 · h=406 2019Q1: Δ+11 · h=417 2019Q2: Δ-9 · h=408 2019Q3: Δ-1 · h=407 2019Q4: Δ+36 · h=443 2020Q1: Δ-39 · h=404 2020Q2: Δ-25 · h=379 2020Q3: Δ+7 · h=386 2020Q4: Δ+46 · h=432 2021Q1: Δ+5 · h=437 2021Q2: Δ+72 · h=509 2021Q3: Δ-58 · h=451 2021Q4: Δ+0 · h=451 2022Q1: Δ+7 · h=458 2022Q2: Δ+4 · h=462 2022Q3: Δ+2 · h=464 2022Q4: Δ+17 · h=481 2023Q1: Δ-12 · h=469 2023Q2: Δ+0 · h=469 2023Q3: Δ+12 · h=481 2023Q4: Δ+16 · h=497 2024Q1: Δ-23 · h=474 2024Q2: Δ-21 · h=453 2024Q3: Δ+23 · h=476 2024Q4: Δ+30 · h=506 2025Q1: Δ+40 · h=546 2025Q2: Δ-47 · h=499 2025Q3: Δ-1 · h=498 2025Q4: Δ+70 · h=568 2026Q1: Δ+0 · h=568 2018Q1: holders=320 2018Q2: holders=369 2018Q3: holders=394 2018Q4: holders=406 2019Q1: holders=417 2019Q2: holders=408 2019Q3: holders=407 2019Q4: holders=443 2020Q1: holders=404 2020Q2: holders=379 2020Q3: holders=386 2020Q4: holders=432 2021Q1: holders=437 2021Q2: holders=509 2021Q3: holders=451 2021Q4: holders=451 2022Q1: holders=458 2022Q2: holders=462 2022Q3: holders=464 2022Q4: holders=481 2023Q1: holders=469 2023Q2: holders=469 2023Q3: holders=481 2023Q4: holders=497 2024Q1: holders=474 2024Q2: holders=453 2024Q3: holders=476 2024Q4: holders=506 2025Q1: holders=546 2025Q2: holders=499 2025Q3: holders=498 2025Q4: holders=568 2026Q1: holders=568 -72 -36 +0 +36 +72 288443597 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 11 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 6%
2025Q1 Top 4%
2024Q4 Top 17%
2024Q3 Top 14%
2023Q3 Top 15%
2021Q2 Top 1%
2020Q4 Top 13%
2019Q4 Top 11%

Options Sentiment

Put holders
9
QoQ: -1
Call holders
8
QoQ: -5

See methodology →

Fundamentals

PE (TTM)
2152.2
EPS (TTM)
$0.11
EPS YoY
-98.5%
Revenue (TTM)
$4.4B
Revenue YoY
+9.2%
Quarterly Revenue & EPS (4Y)
2022-06-30: $0.9B 2022-09-30: $0.9B 2022-12-31: $1.0B 2023-03-31: $0.9B 2023-06-30: $1.0B 2023-09-30: $1.0B 2023-12-31: $1.0B 2024-03-31: $0.9B 2024-06-30: $1.0B 2024-09-30: $1.1B 2024-12-31: $1.1B 2025-03-31: $0.9B 2025-06-30: $1.0B 2025-09-30: $1.1B 2025-12-31: $1.2B 2026-03-31: $1.1B 2022-06-30: EPS 0.55 2022-09-30: EPS -0.31 2022-12-31: EPS -3.85 2023-03-31: EPS 1.04 2023-06-30: EPS 1.52 2023-09-30: EPS 2.14 2023-12-31: EPS 1.40 2024-03-31: EPS -0.23 2024-06-30: EPS 2.49 2024-09-30: EPS 3.42 2024-12-31: EPS 2.97 2025-03-31: EPS -1.52 2025-06-30: EPS -11.74 2025-09-30: EPS 4.08 2025-12-31: EPS 3.34 2026-03-31: EPS 4.43 0B 0.6B 1.2B $B -12.91 -4.02 4.87 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 21 2023-09-30: PE 143.32023-12-31: PE 20.82024-03-31: PE 22.62024-06-30: PE 19.12024-09-30: PE 17.22024-12-31: PE 15.52025-03-31: PE 14.82026-03-31: PE 2079.7 13 1099 2184 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)